Paradigm Biocapital Advisors LP

CIK

1855655

City

NEW YORK

State / Country

NY

Stock

OLMA — Olema Pharmaceuticals, Inc.

Top Portfolio Positions

35 positions · $4,934,767,608 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio	Open
ACLX	Arcellx, Inc. Healthcare	5,774,016	$662,972,517	13.43%
RVMD	Revolution Medicines, Inc. Healthcare	6,655,703	$647,267,116	13.12%
NUVL	Nuvalent, Inc. Healthcare	5,324,433	$545,488,160	11.05%
PCVX	Vaxcyte, Inc. Healthcare	4,793,020	$278,522,392	5.64%
EWTX	Edgewise Therapeutics, Inc. Healthcare	7,365,038	$231,998,697	4.70%
GMAB	Genmab A/S Healthcare	7,967,836	$213,777,039	4.33%
INSM	INSMED Inc Healthcare	1,254,488	$205,133,877	4.16%
TARS	Tarsus Pharmaceuticals, Inc. Healthcare	2,562,154	$179,735,103	3.64%
BLTE	Belite Bio, Inc Healthcare	1,114,784	$177,741,160	3.60%
ERAS	Erasca, Inc. Healthcare	10,392,702	$168,153,918	3.41%

Portfolio Trend

18 quarters · across all stocks

Holdings in OLMA

Compact Export CSV

Shares Held

Position Value (USD)

14 quarters on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$119,586,788	8,020,576	+6.3%	Shares	Sole	2026-05-15
2025-12-31	$188,604,300	7,544,172	+11.0%	Shares	Sole	2026-02-17
2025-09-30	$66,514,943	6,794,172	+0.4%	Shares	Sole	2025-11-14
2025-06-30	$28,815,372	6,764,172	+0.3%	Shares	Sole	2025-08-14
2025-03-31	$25,346,806	6,741,172	-9.3%	Shares	Sole	2025-05-15
2024-12-31	$43,313,139	7,429,355	+1.7%	Shares	Sole	2025-02-14
2024-12-31	$42,587,975	7,304,970	+32.7%	Shares	Sole	2025-02-14
2024-09-30	$65,712,984	5,503,600	-30.4%	Shares	Sole	2024-11-14
2024-06-30	$85,516,952	7,903,600	0.0%	Shares	Sole	2024-08-14
2024-03-31	$89,468,752	7,903,600	0.0%	Shares	Sole	2024-05-15
2023-12-31	$110,887,508	7,903,600	+1.3%	Shares	Sole	2024-02-14
2023-09-30	$96,374,460	7,803,600	+109.2%	Shares	Sole	2023-11-14
2023-06-30	$33,691,345	3,731,046	+56.6%	Shares	Sole	2023-08-14
2023-03-31	$8,266,848	2,382,377	—	Shares	Sole	2023-05-15
No 13F history on record for this holder in this stock.